Stanford University
Showing 3,761-3,780 of 7,913 Results
-
Kristina Kudelko
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program
-
Ellen Kuhl
Catherine Holman Johnson Director of Stanford Bio-X, Walter B Reinhold Professor in the School of Engineering, Professor of Mechanical Engineering and, by courtesy, of Bioengineering
Current Research and Scholarly Interestscomputaitonal simulation of brain development, cortical folding, computational simulation of cardiac disease, heart failure, left ventricular remodeling, electrophysiology, excitation-contraction coupling, computer-guided surgical planning, patient-specific simulation
-
Michael Kuiken
Distinguished Visiting Fellow, HOOVER RESEARCH
BioMike Kuiken is a Distinguished Visiting Fellow at Stanford University's Hoover Institution and serves as Vice Chair of the U.S.-China Economic and Security Review Commission.
In the private sector, Mike is the Managing Member of Silver Valley Strategies, where he advises founders, CEOs, and investors on geopolitical and government strategies. He is an advisor to the Special Competitive Studies Project (SCSP) and a member of Anthropic's National Security and Public Sector Advisory Council. He serves on the boards of the National Defense Industrial Association and the Planetary Science Institute. His writing has appeared in the Financial Times, Newsweek, and the Boston Globe.
Mike previously served as Senate Majority Leader Schumer's National Security Advisor. He was a 'Gang of Eight' staffer for over seven years. He architected the legislative strategy to pass the CHIPS and Science Act and played a key role in establishing the Senate's Artificial Intelligence Insight Forums. Prior to the Leader's office, Mike spent over a decade on the Senate Armed Services Committee, a career that began with the late Senator Carl Levin.
His work has spanned the most consequential challenges of the post-9/11 era—from the wars in Afghanistan and Iraq to today's strategic competition with China. He has shaped U.S. responses to the Arab Spring, Russia's invasion of Ukraine, economic statecraft, and strategic cyber competition, working on the ground in over 85 countries to bring a frontline perspective to national policy.
Mike earned his B.A. in Political Science and Economics from Calvin University and his M.A. in International Commerce and Policy from George Mason University. -
Andre Kumar MD, MEd
Clinical Associate Professor, Medicine
BioDr. Andre Kumar is a Clinical Associate Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.
Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.
Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of free educational content for POCUS, including videos for the Stanford Medicine 25 series, New England Journal of Medicine, and JAMA, which have amassed over 1,000,000 views worldwide.
Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program and Co-Director of Clinical Reasoning at Stanford School of Medicine. He previously served as President for the Society of Hospital Medicine Bay Area and Director of the Rathmann Medical Education Fellowship.
List of publications: https://bit.ly/3eop95i
ClinicalTrials.Gov registration:
https://bit.ly/2TizOmD
https://bit.ly/2zeNBjJ
Media:
https://shorturl.at/rNU46
https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
https://bit.ly/33MZa0O
https://bit.ly/3t8HE2u
https://wb.md/2zfjY1N -
Anshul Kundaje
Associate Professor of Genetics and of Computer Science
Current Research and Scholarly InterestsWe develop statistical and machine learning frameworks to model gene regulation and decipher the genetic and molecular basis of disease
-
Christian Kunder
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.
I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.
I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies.
